Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Elenbecestat

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 484,550Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biogen’s R&D chief Ehlers heads for the exit
    Biogen’s R&D chief Ehlers heads for the exit

    02 Oct 2019

    // Phil Taylor PMLIVE

    http://www.pmlive.com/pharma_news/biogens_r_and_d_chief_ehlers_heads_for_the_exit_1311677

    Phil Taylor PMLIVE
    02 Oct 2019
    Share Share
    Biogen loses another pipeline drug to toxicity concerns
    Biogen loses another pipeline drug to toxicity concerns

    20 Sep 2019

    // Phil Taylor PMLIVE

    http://www.pmlive.com/pharma_news/biogen_loses_another_pipeline_drug_to_toxicity_concerns_1301871

    Phil Taylor PMLIVE
    20 Sep 2019
    Share Share
    Biogen, Eisai throw out remaining Alzheimer's BACE hope
    Biogen, Eisai throw out remaining Alzheimer's BACE hope

    14 Sep 2019

    // Ben Adams FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/biogen-eisai-throw-out-remaining-alzheimer-s-bace-hope

    Ben Adams FIERCE BIOTECH
    14 Sep 2019
    Share Share
    New Data about Eisai's Latest Dementia Pipeline
    New Data about Eisai's Latest Dementia Pipeline

    11 Jul 2019

    // PR NEWSWIRE

    https://www.prnewswire.com:443/news-releases/new-data-in-2-oral-and-13-poster-presentations-about-eisais-latest-dementia-pipeline-including-ban2401-elenbecestat-and-lemborexant-to-be-presented-at-alzheimers-association-international-conference-300883623.html

    PR NEWSWIRE
    11 Jul 2019
    Share Share
    Eisai to Present Latest Research about Alzheimer's Disease/Dementia Pipeline
    Eisai to Present Latest Research about Alzheimer's Disease/Dementia Pipeline

    23 Mar 2019

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/eisai-to-present-latest-research-about-alzheimers-diseasedementia-pipeline-at-the-14th-international-conference-on-alzheimers--parkinsons-diseases-300816842.html

    PRNEWSWIRE
    23 Mar 2019
    Share Share
    Eisai to present latest research on Alzheimer's Disease / Dementia Pipeline
    Eisai to present latest research on Alzheimer's Disease / Dementia Pipeline

    23 Mar 2019

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/25/13083/eisai-to-present-latest-research-on-alzheimers-disease-dementia-pipeline-.html

    BIOSPECTRUMASIA
    23 Mar 2019
    Share Share